Natasha Vanegas

641 total citations
25 papers, 426 citations indexed

About

Natasha Vanegas is a scholar working on Infectious Diseases, Molecular Biology and Molecular Medicine. According to data from OpenAlex, Natasha Vanegas has authored 25 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Molecular Medicine. Recurrent topics in Natasha Vanegas's work include Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (7 papers). Natasha Vanegas is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (13 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial biofilms and quorum sensing (7 papers). Natasha Vanegas collaborates with scholars based in Colombia, Australia and Spain. Natasha Vanegas's co-authors include Javier Escobar-Pérez, Jaime Moreno, Ricaurte Alejandro Marquez-Ortíz, Aura Lucía Leal, César A. Arias, Elizabeth Castañeda, Sandra Rincón, Lorena Díaz, Jinnethe Reyes and Carlos Álvarez and has published in prestigious journals such as PLoS ONE, Cancer Cell and Scientific Reports.

In The Last Decade

Natasha Vanegas

25 papers receiving 413 citations

Peers

Countries citing papers authored by Natasha Vanegas

Since Specialization

Citations

This map shows the geographic impact of Natasha Vanegas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Vanegas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Vanegas more than expected).

Fields of papers citing papers by Natasha Vanegas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natasha Vanegas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Vanegas. The network helps show where Natasha Vanegas may publish in the future.

Co-authorship network of co-authors of Natasha Vanegas

This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Vanegas. A scholar is included among the top collaborators of Natasha Vanegas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Vanegas. Natasha Vanegas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Worldwide Dissemination of blaKPC Gene by Novel Mobilization Platforms in Pseudomonas aeruginosa: A Systematic Review 2023 ·Antibiotics ·(unknown), (unknown), (unknown), Ricaurte Alejandro Marquez-Ortíz, (unknown), Natasha Vanegas, Gloria Inés Lafaurie, Leandro Chambrone, Javier Escobar-Pérez	18
2	Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern 2023 ·Frontiers in Immunology ·(unknown), Nancy B. Amaro-Mugridge, (unknown), (unknown), Natasha Vanegas, Kumar Visvanathan, Bryan R.G. Williams, Jennifer A. MacDiarmid, Himanshu Brahmbhatt	5
3	Within patient genetic diversity of blaKPC harboring Klebsiella pneumoniae in a Colombian hospital and identification of a new NTEKPC platform 2021 ·Scientific Reports ·(unknown), (unknown), (unknown), Aura Lucía Leal, Ricaurte Alejandro Marquez-Ortíz, (unknown), (unknown), (unknown), (unknown), Natasha Vanegas, Jorge Alberto Cortés, Javier Escobar-Pérez	12
4	Cyto-Immuno-Therapy for Cancer: A Pathway Elicited by Tumor-Targeted, Cytotoxic Drug-Packaged Bacterially Derived Nanocells 2020 ·Cancer Cell ·Sharon M. Sagnella, (unknown), (unknown), Ebru Boslem, Estefanía Martino‐Echarri, Katarzyna Smolarczyk, (unknown), Natasha Vanegas, (unknown), Stephen Clarke, John A. Boockvar, Jennifer A. MacDiarmid, Himanshu Brahmbhatt	43
5	Genomic Epidemiology of NDM-1-Encoding Plasmids in Latin American Clinical Isolates Reveals Insights into the Evolution of Multidrug Resistance 2017 ·Genome Biology and Evolution ·Ricaurte Alejandro Marquez-Ortíz, Leanne Haggerty, Narda Olarte, Carolina Duarte, Ulises Garza–Ramos, Jesús Silva-Sánchez, (unknown), Eby Sim, (unknown), (unknown), (unknown), Jaime E. Castellanos, Ian G. Charles, Natasha Vanegas, Javier Escobar-Pérez, Nicola K. Petty	48
6	Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models 2017 ·PLoS ONE ·Mohamed A. Alfaleh, Christopher B. Howard, Ilya Sedliarou, Martina L. Jones, (unknown), Natasha Vanegas, Jocelyn Weiss, (unknown), Christopher J. de Bakker, Michael Milne, Bree Rumballe, Jennifer A. MacDiarmid, Himanshu Brahmbhatt, Stephen M. Mahler	14
7	Emergence and spread of a new community-genotype methicillin-resistant Staphylococcus aureus clone in Colombia 2017 ·BMC Infectious Diseases ·Javier Escobar-Pérez, Niradiz Reyes, Ricaurte Alejandro Marquez-Ortíz, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Natasha Vanegas	6
8	USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children 2014 ·International Journal of Infectious Diseases ·Ricaurte Alejandro Marquez-Ortíz, Martha I. Álvarez-Olmos, Javier Escobar-Pérez, Aura Lucía Leal, (unknown), (unknown), (unknown), (unknown), (unknown), Natasha Vanegas	12
9	Establishment and multi drug resistance evolution of ST235 Pseudomonas aeruginosa strains in the intensive care unit of a Colombian hospital 2014 ·Research in Microbiology ·Elena Martínez, (unknown), (unknown), (unknown), Natasha Vanegas, H. W. Stokes	10
10	Emerging and existing mechanisms co-operate in generating diverse β-lactam resistance phenotypes in geographically dispersed and genetically disparate Pseudomonas aeruginosa strains 2013 ·Journal of Global Antimicrobial Resistance ·Elena Martínez, (unknown), Carolina Márquez, Elisabet Vilacoba, Daniela Centrón, Aura Lucía Leal, (unknown), Sandra Yamile Saavedra, (unknown), Natasha Vanegas, H. W. Stokes	4
11	Detection of a New Community Genotype Methicillin-Resistant Staphylococcus aureus Clone That Is Unrelated to the USA300 Clone and That Causes Pediatric Infections in Colombia 2012 ·Journal of Clinical Microbiology ·Javier Escobar-Pérez, Ricaurte Alejandro Marquez-Ortíz, Martha I. Álvarez-Olmos, Aura Lucía Leal, (unknown), Natasha Vanegas	14
12	Design of two molecular methodologies for the rapid identification of Colombian community-acquired methicillin-resistant Staphylococcus aureus isolates. 2012 ·PubMed ·Javier Escobar-Pérez, (unknown), (unknown), (unknown), (unknown), (unknown), Natasha Vanegas	20
13	Diseño de dos metodologías moleculares para la rápida identificación de aislamientos de Staphylococcus aureus resistente a meticilina asociados a la comunidad en Colombia 2012 ·Biomédica ·Javier Escobar-Pérez, (unknown), (unknown), (unknown), (unknown), (unknown), Natasha Vanegas	1
14	Dissemination of Multiple Drug Resistance Genes by Class 1 Integrons in Klebsiella pneumoniae Isolates from Four Countries: a Comparative Study 2011 ·Antimicrobial Agents and Chemotherapy ·Piklu Roy Chowdhury, (unknown), Natasha Vanegas, Elena Martínez, John Merlino, Andrea Karina Merkier, (unknown), Gerardo González‐Rocha, Graciela Borthagaray, Daniela Centrón, (unknown), Carolina Márquez, H. W. Stokes	56
15	Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia 2009 ·American Journal of Infection Control ·Carlos Álvarez, (unknown), Aura Lucía Leal, Jaime Moreno, Sebastián Méndez-Álvarez, Milcíades Ibáñez‐Pinilla, Natasha Vanegas	41
16	Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina:reporte de dos casos en Colombia 2009 ·Biomédica ·(unknown), Camilo González, (unknown), Natasha Vanegas, (unknown), (unknown), (unknown), Carlos Álvarez	5
17	Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance 2007 ·International Journal of Infectious Diseases ·Jinnethe Reyes, Marylin Hidalgo, Lorena Díaz, Sandra Rincón, Jaime Moreno, Natasha Vanegas, Elizabeth Castañeda, César A. Arias	46
18	Transcriptional Analysis of the vanC Cluster from Enterococcus gallinarum Strains with Constitutive and Inducible Vancomycin Resistance 2005 ·Antimicrobial Agents and Chemotherapy ·Diana Panesso, (unknown), Natasha Vanegas, Peter E. Reynolds, Patrice Courvalin, César A. Arias	13
19	Differential expression of Ran GTPase during HMBA-induced differentiation in murine erythroleukemia cells 2003 ·Leukemia Research ·Natasha Vanegas, Ana García-Sacristán, Luis A. López‐Fernández, Mario Párraga, Jesús del Mazo, Pablo Hernández, Jorge B. Schvartzman, Dora B. Krimer	15
20	Cloning, sequencing and expression in MEL cells of a cDNA encoding the mouse ribosomal protein S51The nucleotide sequence reported in this paper has been submitted to the GenBank/EMBL Data Bank under the accession number U78085.1 1997 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Natasha Vanegas, (unknown), David Santamarı́a, Pablo Hernández, Jorge B. Schvartzman, Dora B. Krimer	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact